Nolan Garry Ph.D. 4/A
4/A · Akoya Biosciences, Inc. · Filed Mar 27, 2023
Insider Transaction Report
Form 4/AAmended
Nolan Garry Ph.D.
Director
Transactions
- Sale
Common Stock
2022-12-13$13.25/sh−100$1,325→ 555,084 total
Footnotes (1)
- [F1]The Form 4/A is being filed to correct the date of the transaction which was inadvertently reported as occurring on 12/13/2021.